Key result
Triglyceride-deposit cardiomyovasculopathy is linked to a smaller lipid area ratio and increased MACE.
Why the study?
Plaque characteristics and prognosis of triglyceride-deposit cardiomyovasculopathy (TGCV) in patients with diffuse coronary artery disease remain unclear.
Does triglyceride-deposit cardiomyovasculopathy alter coronary plaque morphology and worsen clinical outcomes in patients with diffuse coronary artery disease?
Observational (n=31)
No
Does triglyceride-deposit cardiomyovasculopathy alter coronary plaque morphology and worsen clinical outcomes in patients with diffuse coronary artery disease?
Absolute Event Rate: 20% vs 23%
p-value: p=0.02
In patients with diffuse coronary artery disease, TGCV is characterized by a smaller lipid area on IB-IVUS and is associated with a higher rate of major adverse cardiovascular events.
May signal higher MACE risk in triglyceride-deposit cardiomyovasculopathy despite lower lipid area; hypothesis-generating, needs prospective validation.
Triglyceride-deposit cardiomyovasculopathy (TGCV) is characterized by diffuse narrowing of the coronary arteries because of triglyceride-deposit atherosclerosis. However, the plaque characteristics and prognosis of TGCV in patients with diffuse coronary artery disease remain unclear. This study aimed to describe the morphology of coronary arteries in TGCV using integrated backscatter intravascular ultrasound (IB-IVUS) and assess the effects on clinical outcomes. This single-center, retrospective observational study compared the IB-IVUS findings and clinical outcomes of patients with native coronary lesions of TGCV with those of patients with non-TGCV, all of whom had diffuse coronary artery disease. TGCV was diagnosed as (1) a low washout rate of iodine-123-β-methyl iodophenyl-pentadecanoic acid (BMIPP; <10%) on BMIPP single-photon emission computed tomography and (2) diffuse narrowing of the coronary arteries on coronary angiography. Thirty-one patients with diffuse coronary artery disease who underwent percutaneous coronary intervention were enrolled. Among these patients 10 (32%) were diagnosed with TGCV. IB-IVUS revealed that TGCV lesions had a significantly smaller ratio of the lipid area than non-TGCV lesions (20% ± 0.8% vs 23% ± 0.5%, p = 0.02). Conversely, the ratio of the calcification area tended to be larger. The Kaplan–Meier analysis revealed a significant increase in the rates of major adverse cardiovascular events in the TGCV group ( p = 0.01). Patients with diffuse coronary artery disease present TGCV characterized by a smaller ratio of the lipid area. TGCV might be associated with worse clinical outcomes. The study findings may contribute to its early diagnosis and management.
No takes yet. Share an insight, caveat, or question.
Ikenaga et al. (2025) conducted an observational in diffuse coronary artery disease (n=31). Triglyceride-deposit cardiomyovasculopathy (TGCV) vs. non-TGCV was evaluated on ratio of the lipid area (p=0.02). Triglyceride-deposit cardiomyovasculopathy was associated with a smaller ratio of lipid area (20% vs 23%, p=0.02) and increased rates of major adverse cardiovascular events (p=0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: